Lineage Cell Therapeutics, Inc. Quarterly Preferred Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Summary
Lineage Cell Therapeutics, Inc. quarterly Preferred Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Lineage Cell Therapeutics, Inc. Preferred Stock, Shares Authorized for the quarter ending September 30, 2024 was 2M shares, unchanged year-over-year.
Preferred Stock, Shares Authorized, Quarterly (shares)
Preferred Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2M 0 0% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 2M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 2M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 2M 0 0% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 2M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 2M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 2M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 2M 0 0% Dec 31, 2022 10-K 2024-03-07
Q3 2022 2M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 2M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 2M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 2M 0 0% Dec 31, 2021 10-K 2023-03-09
Q3 2021 2M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 2M 0 0% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 2M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 2M 0 0% Dec 31, 2020 10-K 2022-03-10
Q3 2020 2M 0 0% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 2M 0 0% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 2M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 2M 0 0% Dec 31, 2019 10-K 2021-03-11
Q3 2019 2M 0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 2M 0 0% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 2M 0 0% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 2M 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 2M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 2M 0 0% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 2M 0 0% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 2M 0 0% Dec 31, 2017 10-K 2019-03-14
Q3 2017 2M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 2M 0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 2M 0 0% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 2M 0 0% Dec 31, 2016 10-K 2018-03-15
Q3 2016 2M 0 0% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 2M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 2M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 2M 0 0% Dec 31, 2015 10-K 2017-03-16
Q3 2015 2M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 2M 0 0% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 2M 0 0% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 2M 0 0% Dec 31, 2014 10-K 2016-03-15
Q3 2014 2M 0 0% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 2M 0 0% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 2M +1M +100% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 2M +1M +100% Dec 31, 2013 10-K 2015-03-11
Q3 2013 2M +1M +100% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 2M +1M +100% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 1M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 1M 0 0% Dec 31, 2012 10-K 2014-03-17
Q3 2012 1M 0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 1M 0 0% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 1M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 1M 0 0% Dec 31, 2011 10-K 2013-03-18
Q3 2011 1M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 1M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 1M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.